Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
Journal
International Journal of Cardiology
Journal Volume
241
Pages
1-5
Date Issued
2017
Author(s)
Chien S.-C.
Chen C.-Y.
Leu H.-B.
Su C.-H.
Yin W.-H.
Tseng W.-K.
Lin T.-H.
Chang K.-C.
Wang J.-H.
Yeh H.-I.
Chen J.-W.
Abstract
Objective Coronary heart disease (CHD) is a leading cause of death in developed countries. Exploration of indicators to identify high risk individuals who develop adverse outcomes despite stable baseline condition is important. This study is to evaluate the association between serum albumin concentration and cardiovascular (CV) outcomes in individuals of stable CHD. Methods Seven-hundred–thirty-four participants from Biosignature study, a nationwide prospective cohort study aimed to identity risk factors among patients with stable CHD, were enrolled for analysis. They were divided into low serum albumin group (baseline albumin concentration
SDGs
Other Subjects
albumin; cholesterol; glucose; hemoglobin; biological marker; serum albumin; adult; adverse outcome; age; aged; albumin blood level; Article; cardiovascular disease; cardiovascular risk; cause of death; cholesterol blood level; cohort analysis; controlled study; diabetic patient; disease association; estimated glomerular filtration rate; female; follow up; glucose blood level; heart left ventricle ejection fraction; hemoglobin blood level; high risk patient; human; ischemic heart disease; major clinical study; male; mortality rate; priority journal; prognosis; prospective study; risk assessment; blood; clinical trial; coronary artery disease; diagnostic imaging; metabolism; middle aged; multicenter study; risk factor; Taiwan; very elderly; Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Serum Albumin; Taiwan
Type
journal article